Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Aptose Biosciences | APTO | 27. nov 2024 | 0.18 | +0.56 |
APx Acquisition I A | APXI | 27. nov 2024 | 11.89 | 0.00 |
APx Acquisition I Unit | APXIU | 27. nov 2024 | 11.55 | 0.00 |
Apyx Medical | APYX | 27. nov 2024 | 1.69 | +16.55 |
Aqua Metals | AQMS | 27. nov 2024 | 2.30 | +1.77 |
AquaBounty Technologies | AQB | 27. nov 2024 | 0.96 | -2.53 |
Aquaron Acquisition | AQU | 27. nov 2024 | 11.10 | 0.00 |
Aquaron Acquisition Units | AQUNU | 27. nov 2024 | 11.15 | 0.00 |
Aquestive Therapeutics | AQST | 27. nov 2024 | 5.16 | +5.74 |
Aramark | ARMK | 27. nov 2024 | 40.77 | -3.43 |
ARB IOT Group | ARBB | 27. nov 2024 | 0.51 | +10.82 |
Arbe Robotics | ARBE | 27. nov 2024 | 1.78 | -6.81 |
Arbor Realty Trust | ABR | 27. nov 2024 | 14.80 | -0.27 |
Arbor Realty Trust D Pref | ABR-D | 27. nov 2024 | 19.22 | -0.05 |
Arbor Realty Trust E Pref | ABR-E | 27. nov 2024 | 18.79 | -2.29 |
Arbor Realty Trust F Pref | ABR-F | 27. nov 2024 | 21.25 | +0.24 |
Arbutus Biopharma | ABUS | 27. nov 2024 | 3.47 | +1.76 |
ARC Document Solutions | ARC | 27. nov 2024 | 3.39 | 0.00 |
Arcadia Biosciences | RKDA | 27. nov 2024 | 2.76 | 0.00 |
Arcadium Lithium | ALTM | 27. nov 2024 | 5.23 | 0.00 |
ArcBest | ARCB | 27. nov 2024 | 113.50 | +0.40 |
Arcellx | ACLX | 27. nov 2024 | 89.07 | -2.08 |
Arcelor Mittal ADR | MT | 27. nov 2024 | 24.56 | +2.59 |
Arch Capital F Pref | ACGLO | 27. nov 2024 | 22.65 | 0.00 |
Arch Capital G | ACGLN | 27. nov 2024 | 19.63 | -0.41 |
Arch Capital Group | ACGL | 27. nov 2024 | 100.74 | +0.33 |
Arch Resources A | ARCH | 27. nov 2024 | 173.36 | -0.58 |
Archer Aviation A | ACHR | 27. nov 2024 | 8.08 | +11.91 |
Archer Daniels Midland | ADM | 27. nov 2024 | 54.37 | +1.21 |
Archrock | AROC | 27. nov 2024 | 24.92 | -1.27 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.